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Correspondence
We appreciate the comments by Dr Maini regarding our recent 
article on outcome of percutaneous left-ventricular support with the 
Impella-2.5 assist device in acute cardiogenic shock.1 In this article, 
we summarize the results of real-world Impella-2.5 use in Europe 
outside of randomized trials, where the device is frequently used as 
last resort option in patients unresponsive to vasopressors, revascular-
ization, and intra-aortic balloon pump support.
We agree with Dr Maini in emphasizing the fact that the disappoint-
ing data of the EUROSHOCK Registry likely reflects the selection of the 
most severely ill patients who have failed first-line treatment of cardio-
genic shock. The lack of a control group in this registry hampers definite 
conclusions on efficacy of Impella-2.5 support at this point. However, 
decrease in plasma lactate after the beginning of Impella support suggests 
at least partial reversal of hypoperfusion and supports the hemodynamic 
efficacy of the device. As suggested in the article, earlier institution of 
support and rapid escalation to more powerful assist devices could be a 
recommended strategy in patients failing to improve, which, however, is 
currently rather based on experience than actual data.1,2
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